Lili Yu
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Health Informatics top 5%
Papers in
-
- Epigenetics and DNA Methylation 13
- RNA modifications and cancer 9
- Plant Gene Expression Analysis 4
- CRISPR and Genetic Engineering 4
- Oncology 21
- Co-authors
- Zehua Wang (7 shared papers)Jing Cai (7 shared papers)Weimin Huang (4 shared papers)Wancheng Chen (4 shared papers)Qibiao Wu (17 shared papers)Ziyuan Lu (2 shared papers)Jiaochan Han (1 shared paper)Yang Xu (8 shared papers)
- Journals
- Medicine (4 papers)Oncotarget (3 papers)Evidence-based Complementary and Alternative Medicine (3 papers)Phytomedicine (3 papers)Current Issues in Molecular Biology (3 papers)
- Partner nations
- ChinaMacaoUnited States
In The Last Decade
Lili Yu
116 papers receiving 2.5k citations
Lili Yu's Hit Papers
Peers
Comparison fields: 5 of 138
- Cancer Research 549
- Health Informatics 35
- Pathology and Forensic Medicine 335
- Reproductive Medicine 154
- Molecular Biology 1.2k
Countries citing papers authored by Lili Yu
This map shows the geographic impact of Lili Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lili Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lili Yu more than expected).
Fields of papers citing papers by Lili Yu
This network shows the impact of papers produced by Lili Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lili Yu. The network helps show where Lili Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lili Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 276 | |
| 2 | 2010 | 128 | |
| 3 | 2016 | 114 | |
| 4 | 2017 | 107 | |
| 5 | 2012 | 98 | |
| 6 | 2020 | 74 | |
| 7 | 2023 | 64 | |
| 8 | 2023 | 62 | |
| 9 | 2010 | 57 | |
| 10 | 2022 | 55 | |
| 11 | 2018 | 51 | |
| 12 | 2018 | 50 | |
| 13 | 2022 | 47 | |
| 14 | 2016 | 45 | |
| 15 | Expression and clinical implications of homeobox gene Six1 in cervical cancer cell lines and cervical epithelial tissues. | 2010 | 36 |
| 16 | 2016 | 34 | |
| 17 | 2021 | 34 | |
| 18 | 2022 | 33 | |
| 19 | 2017 | 32 | |
| 20 | 2022 | 32 |
About Lili Yu
Lili Yu is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Genetics, having authored 123 papers that have together received 2.5k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (13 papers), RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (8 papers), Genetic Associations and Epidemiology (6 papers), Cancer, Lipids, and Metabolism (4 papers), Plant Gene Expression Analysis (4 papers), CRISPR and Genetic Engineering (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). The work is most often cited by research in Cancer Research (549 citations), Health Informatics (35 citations), Pathology and Forensic Medicine (335 citations), Reproductive Medicine (154 citations) and Molecular Biology (1.2k citations). Lili Yu has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Zehua Wang, Jing Cai, Weimin Huang, Wancheng Chen, Qibiao Wu, Ziyuan Lu, Jiaochan Han, Yang Xu, Yang Xiao and Chenyan Shi. Their work appears in journals such as Medicine, Oncotarget, Evidence-based Complementary and Alternative Medicine, Phytomedicine and Current Issues in Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.